Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression.
about
Neuroinflammation in the normal aging hippocampusDifferential neuropathic pain sensitivity and expression of spinal mediators in Lewis and Fischer 344 ratsSupraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance.Gabapentin attenuates hyperexcitability in the freeze-lesion model of developmental cortical malformation.Neuronal activity regulates glutamate transporter dynamics in developing astrocytesThe group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease micePharmacology of Alzheimer's disease: appraisal and prospects.Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation.The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian statesSynaptically evoked glutamate transporter currents in Spinal Dorsal Horn Astrocytes.Peroxynitrite and opiate antinociceptive tolerance: a painful reality.Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain.Roles of reactive oxygen and nitrogen species in painToward a new role for plasma membrane sodium-dependent glutamate transporters of astrocytes: maintenance of antioxidant defenses beyond extracellular glutamate clearance.Glial glutamate transporters: new actors in brain signaling.Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.NMDA-receptor activation and nitroxidative regulation of the glutamatergic pathway during nociceptive processing.Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats.Inhibition of the ubiquitin-proteasome activity prevents glutamate transporter degradation and morphine tolerance.Inward currents induced by ischemia in rat spinal cord dorsal horn neurons.Serotonin depletion produces long lasting increase in striatal glutamatergic transmission.Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxide synthase induction and glutamate uptake inhibition.Heterogeneity between hippocampal and septal astroglia as a contributing factor to differential in vivo AMPA excitotoxicity.Supraspinal and spinal effects of L-trans-PDC, an inhibitor of glutamate transporter, on the micturition reflex in rats.Activation of VIP/PACAP type 2 receptor by the peptide histidine isoleucine in astrocytes influences GLAST-mediated glutamate uptake.Activation of group III metabotropic glutamate receptors by endogenous glutamate protects against glutamate-mediated excitotoxicity in the hippocampus in vivo.
P2860
Q28388537-9D621E1F-6694-4B8C-97B8-4B299D601B48Q30440497-34C47876-01A7-4811-B509-D34720BB6855Q33813707-5D6BBD39-B4DB-4F96-8FF4-82E06A07006CQ34266645-0BFC3B0A-A0DA-44E3-A77B-504F5CBB6A00Q35597189-798D9DC8-5721-4A7B-90B5-F80918406955Q36037085-2F5B6E0B-6B8C-4393-B35C-71EB3FD64272Q36071069-97D3916A-D633-4FAC-A8D0-2ED250EEAB25Q36798747-A0B7122C-591E-4447-A516-58AB036D3DF6Q37130756-5C490AFD-14D7-426D-8C06-EDE115758396Q37268387-ACD99A2F-5E5F-4F33-8E01-64307C8C4D89Q37328701-40F25B0C-70E0-4BD7-828B-A1FC59F4A72DQ37765512-DB8CBE93-C2BB-4199-9720-E0568ADEF8A2Q37833285-66200E2E-3D36-491E-BA39-749427F7A492Q37852587-EABF8BF6-8591-41D5-B576-72A4BC2315DDQ37929084-03EBF5CB-CB9E-462F-BDF9-1BBA340DF8ABQ38839272-AEBC1A5A-78AA-4810-8F9E-F17710252D6DQ39603918-C060B924-06E6-49C3-81BE-D5C962EFDCF8Q40735769-866E7305-B65E-4319-B127-E6741C3C5F1EQ41961680-D15DEC2A-89CF-4449-8327-4F3135D8E1A6Q42118122-1298059E-19C9-4784-831D-F59D7A3D3ABCQ42507594-0319FF67-4298-4859-A713-224A4A33515FQ42639183-4CB58750-6738-4F9B-BFAE-3DC038FE1942Q43681037-57DB1283-51DB-49B7-962A-BCFA7B8929F7Q44029783-094CF4E2-1AB6-4195-AB2F-7347DC8F5F10Q44973924-D581645F-54E4-4E32-98A9-B2FB201D4D05Q45745388-C70F7EFA-84FD-4443-9A22-59DBDC70653FQ46808731-636E1B88-6651-4F94-8ADC-41C4C029BC5AQ48709364-0947E99B-0B8E-4B16-B7F7-14031818CE16
P2860
Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@ast
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@en
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@nl
type
label
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@ast
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@en
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@nl
prefLabel
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@ast
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@en
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@nl
P2093
P2860
P1433
P1476
Characterization of striatal l ...... T1 and GADD45 mRNA expression.
@en
P2093
Kerkerian-Le Goff L
Lievens JC
P2860
P304
P356
10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0
P577
2000-02-01T00:00:00Z